STEM News Today
SEE OTHER BRANDS

Global take on science and technology news

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on July 24, 2025

MemoCore Drops – Official Launching Ultimate Cognitive Health Supplement for Memory and Focus

MemoCore Drops – Official Launching Ultimate Cognitive Health Supplement for Memory and Focus

New York City, NY, July 24, 2025 (GLOBE NEWSWIRE) -- MemoCore Drops Launches as a Cognitive Support Supplement to Enhance Memory and Mental Clarity in 2025 Today marks the official launch of MemoCore Drops, a newly developed cognitive support supplement …

Applied Materials to Report Fiscal Third Quarter 2025 Results on August 14, 2025

Applied Materials to Report Fiscal Third Quarter 2025 Results on August 14, 2025

SANTA CLARA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that it will hold its fiscal third quarter 2025 earnings conference call on Thursday, August 14, 2025, at 4:30 p.m. ET / 1:30 p.m. PT. The call will be webcast …

Regeneron Announces the 2025 Winners of the Regeneron Prize for Creative Innovation

Regeneron Announces the 2025 Winners of the Regeneron Prize for Creative Innovation

TARRYTOWN, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 13th annual Regeneron Prize for Creative Innovation (the “Regeneron Prize”), which recognizes and rewards outstanding …

Zefiro Subsidiary P&G Secures Award for Well-Plugging Project Near Columbus, Ohio

Zefiro Subsidiary P&G Secures Award for Well-Plugging Project Near Columbus, Ohio

FORT LAUDERDALE, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that its subsidiary Plants …

Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases

Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases

Matchpoint to receive up to $60 million in upfront payment and research funding, with up to $1 billion in total potential payments, including option exercise fee, development and commercial milestones Matchpoint will lead all research activities through …

Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus

Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus

-Topline Readout Expected in Q3 2026- SOUTH SAN FRANCISCO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today …

American Tungsten Corp. Announces Closing of Upsized $7m Financing

American Tungsten Corp. Announces Closing of Upsized $7m Financing

Vancouver, BC, July 24, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce, further to its news releases of June 30, 2025 and July 17, 2025, the successful …

NETCLASS TECHNOLOGY INC Establishes a Singapore Subsidiary to Drive Global AI Business Expansion

NETCLASS TECHNOLOGY INC Establishes a Singapore Subsidiary to Drive Global AI Business Expansion

SHANGHAI and HONG KONG, July 24, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today announced the …

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

– Peer-reviewed publication in Annals of Clinical and Translational Neurology highlights the use of the MSA Atrophy Index developed to diagnose and track disease progression in Multiple System Atrophy – MELBOURNE, Australia and SAN FRANCISCO, July 24, 2025 …

Algoma Steel Comments on Ongoing Trade Impasse and Prolonged Tariff Environment

Algoma Steel Comments on Ongoing Trade Impasse and Prolonged Tariff Environment

SAULT STE. MARIE, Ontario, July 24, 2025 (GLOBE NEWSWIRE) -- Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of hot and cold rolled steel sheet and plate products, today commented on the ongoing …

Quality Clouds Launches AI Quality Shield for Technology Services Companies to Empower Enterprise Clients with AI Readiness and Orchestration

Quality Clouds Launches AI Quality Shield for Technology Services Companies to Empower Enterprise Clients with AI Readiness and Orchestration

LONDON, July 24, 2025 (GLOBE NEWSWIRE) -- Quality Clouds, a provider of software governance solutions trusted by companies like JPMorgan Chase, Shell, Barclays, and BP, today announced the launch of AI Quality Shield, a new governance suite designed to …

Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025

Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025

JUPITER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2025 financial results on Thursday, August 7, 2025. The company will hold a conference call beginning at …

Apellis Pharmaceuticals to Host Conference Call on July 31, 2025, to Discuss Second Quarter 2025 Financial Results

Apellis Pharmaceuticals to Host Conference Call on July 31, 2025, to Discuss Second Quarter 2025 Financial Results

WALTHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its second quarter 2025 financial results on Thursday, July 31, 2025, at 8:30 …

Award-Winning Breckenridge Distillery Makes Bold Entry into Tequila with Launch of Casa Breck

Award-Winning Breckenridge Distillery Makes Bold Entry into Tequila with Launch of Casa Breck

BRECKENRIDGE, Colo., July 24, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), proudly celebrates International Tequila Day with the launch of Casa …

Microbix Exhibiting & Presenting at ADLM

Microbix Exhibiting & Presenting at ADLM

MISSISSAUGA, Ontario, July 24, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be attending, exhibiting, and presenting at the Association …

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference

Boca Raton, July 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) announced today that additional analyses from its Phase 2 MINDFuL trial evaluating XPro™, a novel selective soluble TNF inhibitor, will be released in an oral presentation at the …

NexGold Continues to Intersect High-Grade Gold Mineralization at the Goldboro Open Pit Gold Project, Including 108.76 g/t Au over 1.40 metres and 67.23 g/t gold over 2.20 metres

NexGold Continues to Intersect High-Grade Gold Mineralization at the Goldboro Open Pit Gold Project, Including 108.76 g/t Au over 1.40 metres and 67.23 g/t gold over 2.20 metres

TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide additional drill results from a recently-completed 26,854-metre diamond drill program initially announced on …

Xtract One Secures SmartGateway Contract with Global Performing Arts Company Famous for Live Entertainment

Xtract One Secures SmartGateway Contract with Global Performing Arts Company Famous for Live Entertainment

TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway screening solution has been chosen by a leading, global performing arts company, known …

TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities

TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities

SAN FRANCISCO, July 24, 2025 (GLOBE NEWSWIRE) -- TCG Labs Soleil, a venture firm integrating dedicated capital with an in-house biotech R…

Biomea Fusion Appoints Julianne Averill to its Board of Directors

Biomea Fusion Appoints Julianne Averill to its Board of Directors

SAN CARLOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the appointment of Julianne Averill to its Board …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions